UEEC (United Health Products) sponsors the CelluSTAT clinical study with NAMSA on 2026-07-10. Note prior capital-structure changes from 2025-12-22.
United Health Products (UEEC) secures a $289,000 senior note and rights to sell up to $4M of common stock, altering its capital structure.